Cyclacel Pharmaceuticals Inc (CYCC) Q1 2024 Earnings Call Transcript Highlights: Navigating ...
Yahoo Finance · 6 days ago
Open | 2.3700 |
High | 2.3700 |
Low | 2.1400 |
Mkt Cap | 3.19M |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 2.2900 |
52 Wk. Low | 1.3000 |
52 Wk. High | 13.2000 |
Related stocks
Company in Berkeley Heights, United States
Cyclacel Pharmaceuticals Inc. is a biotechnology firm based in Berkeley Heights, New Jersey and Dundee, Scotland, developing cancer treatments. Cyclacel was founded in 1996 by David Lane, PhD. Wikipedia
(USD) | Q4 2023 | Y/Y |
---|---|---|
Revenue | 31k | - |
Net Income | -5.27M | - |
Diluted EPS | -2.27 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | -$1.69 | - |
Q1 2024 | -$4.74 | -$2.27 |
Q4 2023 | -$5.89 | -$6.23 |
S&P FuturesES=F | 5,331.00-0.75 (-0.01%) |
Dow FuturesYM=F | 39,928.00-16.00 (-0.04%) |
Nasdaq FuturesNQ=F | 18,743.00-20.00 (-0.11%) |
323.77+1.86% | |
Ethereum USDETH-USD | 3,653.79+17.69% |
18.60+27.66% |